| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Johnson & Johnson is currently enhancing its position in product and service development through strategic participation in healthcare conferences, showcasing its commitment to innovation. The company is also actively shifting its portfolio to focus on high-growth markets, aligning with trends in surgical robotics and elevating its product offerings. However, challenges remain in clinical trials, highlighted by setbacks in drug development that impact the pipeline and patient care. Balancing these positive advancements with the hurdles in drug development will be crucial for future growth. |
| The price action of JOHNSON & JOHNSON (JNJ) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.9 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for JNJ since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.9, and the negative at 0 on 2025-11-14. The forces of and () will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), Sentiment towards Fundamentals (2.5), and Valuation Sentiment (2.6) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| JNJ | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-14 | 0%(0%) | 0 | 0% | 0.9 | 2.5 | -1 | |||||||
| 2025-11-13 | 0%(0%) | 0 | 0% | 0.9 | 3.1 | -1 | |||||||
| 2025-11-12 | 0%(0%) | 0 | 0% | 1 | 3.4 | -1 | |||||||
| 2025-11-11 | 0%(0%) | 0 | 0% | 0.9 | 2.9 | -1 | |||||||
| 2025-11-10 | 0%(0%) | 0 | 0% | 0.3 | 2.6 | -1 | |||||||
| 2025-11-09 | 0%(0%) | 0 | 0% | -0.1 | 0.2 | -1 | |||||||
| 2025-11-08 | 0%(0%) | 0 | 0% | -0.1 | 0.2 | -1 | |||||||
| 2025-11-07 | 0%(0%) | 0 | 0% | -0.1 | 0.4 | -1 | |||||||
| 2025-11-06 | 0%(0%) | 0 | 0% | -0.2 | 0.1 | -1 | |||||||
| 2025-11-05 | 0%(0%) | 0 | 0% | -0.2 | -0.2 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-11-14 17:03:06 The decision to halt the drug trial points to potential regulatory and safety concerns impacting the pharmaceutical industry. |
| 2025-11-14 17:03:06 Confidence among biopharma companies suggests a trend towards growth and optimism within the healthcare sector. |
| 2025-11-14 17:03:06 The activities of investment firms regarding their stakes in major companies like Johnson & Johnson indicate ongoing strategies in the financial markets. |
| 2025-11-14 17:03:06 The halt of the heart drug trial by Bristol Myers Squibb and Johnson & Johnson reflects challenges in clinical drug development and the potential implications for patients. |
| 2025-11-14 17:03:06 The stock performance of Johnson & Johnson is positively highlighted through gradual gains, showcasing investor confidence. |